Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Providence Portland Medical Center | Researchclopedia

Back to institutions

Providence Portland Medical Center

Portland, Oregonhealthcare

2,825

Works

311,986

Citations

233

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Top Researchers

Gordon B. Mills Baylor College of Medicine

3,472 works263,302 citationsh-index: 231

Recent Research

An atlas of transcriptional dynamics in maternal blood over the course of healthy pregnancy

Bjarke Feenstra,Freja Randrup Dahl Hede,et al.

20260 citations

Immune Cell Function and Interaction

Lung Cancer Treatments and Mutations

T-cell and B-cell Immunology

Colorectal Cancer Treatments and Studies

Cancer Genomics and Diagnostics

Pancreatic and Hepatic Oncology Research

Cancer Research and Treatments

Lung Cancer Research Studies

Monoclonal and Polyclonal Antibodies Research

Steven A. Rosenberg National Institutes of Health

1,554 works196,731 citationsh-index: 219

Michael Phillips University of North Carolina at Chapel Hill

548 works192,411 citationsh-index: 91

Mike Clarke Queen's University Belfast

1,129 works174,989 citationsh-index: 105

Antoni Ribas APLA Health

1,710 works162,010 citationsh-index: 158

Josep M. Llovet Icahn School of Medicine at Mount Sinai

791 works153,658 citationsh-index: 151

Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma

Reinhard Dummer,Shahneen Sandhu,et al.

20260 citations

A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

Melissa L. Johnson,Egbert F. Smit,et al.

20260 citations

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion–Positive Non–Small Cell Lung Cancer

Benjamin Besse,Vivek Subbiah,et al.

20260 citations

Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancer

Alan Su,Erin C. Hong,et al.

20260 citations

150TiP A phase Ib/II trial of a PD-1/VEGF bispecific antibody (PF-08634404) in combination with anticancer agents in first-line (1L) for advanced solid tumors (Symbiotic-Lung-20)

E. Felip,Federico Cappuzzo,et al.

20260 citations